申请人:——
公开号:US05726196A1
公开(公告)日:1998-03-10
The disclosure describes a pharmaceutical composition comprising an aromatase-inhibiting effective amount of a compound selected from the group consisting of compounds of the formula (I): ##STR1## including their stereoisomers and salts thereof, wherein R.sup.1 is halogen or phenyl; m is 0, 1, 2 or 3; k and n each are independently 0, 1 or 2; R.sup.2 and R.sup.3 each are independently H or OH; R.sup.6 and R.sup.7 each are independently H or C.sub.1-4 alkyl; R.sup.8 and R.sup.9 each are H or R.sup.8 and R.sup.9 form --C(R.sup.4) (R.sup.5)--C(R.sup.11) (R12)-- bond wherein R.sup.4, R.sup.5, R.sup.11 and R.sup.12 each are independently H or C.sub.1-4 alkyl; Y is N or CH; and R.sup.10 is H or halogen, or R.sup.10 combines with R.sup.2 to form --O-- bond, with proviso that if R.sup.8 and R.sup.9 form --C (R.sup.4) (R.sup.5)--C(R.sup.11) (R.sup.12)-- bond R.sup.3, R.sup.6 and R.sup.7 each are H, and k and n each are 1, then R.sup.2 and R.sup.10 form --O-- bond, and a pharmaceutically acceptable carrier or diluent.
该披露描述了一种药物组合物,包括一种从以下化合物组合中选择的抑制芳香化酶有效量的化合物,其中该组合物的化学结构如下:其中R1是卤素或苯基;m为0、1、2或3;k和n各自独立地为0、1或2;R2和R3各自独立地为H或OH;R6和R7各自独立地为H或C1-4烷基;R8和R9各自为H或R8和R9形成--C(R4)(R5)--C(R11)(R12)--键,其中R4、R5、R11和R12各自独立地为H或C1-4烷基;Y为N或CH;R10为H或卤素,或R10与R2结合形成--O--键,条件是如果R8和R9形成--C(R4)(R5)--C(R11)(R12)--键,那么R3、R6和R7各自为H,k和n各自为1,则R2和R10形成--O--键,以及药用可接受的载体或稀释剂。